BioLine RX Ltd (BLRX) — Long-term Investment Intensity
BioLine RX Ltd (BLRX) has a Long-term Investment Intensity of 1.8% as of March 2018. Long-term investments of ILA1.00 Million represent 1.8% of total assets of ILA56.08 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BLRX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BioLine RX Ltd Long-term Investment Intensity (2017–2017)
This chart shows how BioLine RX Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of March 2018, the intensity stands at 1.8%, reflecting long-term investments of ILA1.00 Million against total assets of ILA56.08 Million ILA. For the complete balance sheet picture, see BioLine RX Ltd balance sheet assets.
Annual Long-term Investment Intensity for BioLine RX Ltd (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for BioLine RX Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BioLine RX Ltd (BLRX) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 1.6% | ILA1.00 Million | ILA60.97 Million | — |